- Home
- EXTR vs CLDX Comparison
EXTR vs CLDX Comparison
Compare EXTR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXTR | CLDX |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1999 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EXTR | CLDX |
|---|---|---|
| Price | $14.34 | $29.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $21.20 | ★ $44.50 |
| AVG Volume (30 Days) | ★ 1.5M | 911.7K |
| Earning Date | 04-28-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,140,067,000.00 | $12,743,000.00 |
| Revenue This Year | $13.15 | $97.61 |
| Revenue Next Year | $7.52 | $252.01 |
| P/E Ratio | $142.60 | ★ N/A |
| Revenue Growth | 2.05 | ★ 87.78 |
| 52 Week Low | $10.11 | $14.40 |
| 52 Week High | $22.89 | $31.85 |
Technical Indicators
Market Signals| Indicator | EXTR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 58.21 |
| Support Level | $13.97 | $24.70 |
| Resistance Level | $14.72 | $30.90 |
| Average True Range (ATR) | 0.44 | 1.57 |
| MACD | 0.09 | 0.16 |
| Stochastic Oscillator | 65.08 | 70.25 |
Price Performance
Historical ComparisonAbout EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.